APO Research
Talk to an analyst

APO RESEARCH · REPORT

Epigenetics NGS Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Epigenetics NGS Service Market Analysis and Forecast 2026-2032

16 April 2026186 pages

Choose your research edition.

Industry ResearchEpigenetics NGS Service Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Epigenetics NGS Service Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Epigenetics NGS Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Epigenetics NGS Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Epigenetics NGS Service Market Analysis and Forecast 2026-2032186 pages · $4,950 USD

Market perspective

The global Epigenetics NGS Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Epigenetics NGS Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Epigenetics NGS Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Epigenetics NGS Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Epigenetics NGS Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Epigenetics NGS Service include Active Motif, Agilent, Zymo Research, Celemics, EpiGentek, GENEWIZ from Azenta, Thermo Fisher Scientific, GenomeScan and Hologic Diagenode, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Epigenetics NGS Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Epigenetics NGS Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Epigenetics NGS Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Epigenetics NGS Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Epigenetics NGS Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Epigenetics NGS Service revenue, projected growth trends, production technology, application and end-user industry.

Epigenetics NGS Service Segment by Company

Active Motif

Agilent

Zymo Research

Celemics

EpiGentek

GENEWIZ from Azenta

Thermo Fisher Scientific

GenomeScan

Hologic Diagenode

Illumina

Macrogen

Novogene

Roche Sequencing Solutions

SeqMatic

Epigenetics NGS Service Segment by Type

DNA Methylation Sequencing

Histone Modification Sequencing

3D Genome Sequencing

Others

Epigenetics NGS Service Segment by Application

Clinical Diagnostics

Basic Research

Drug Development

Agricultural Breeding

Others

Epigenetics NGS Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epigenetics NGS Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Epigenetics NGS Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epigenetics NGS Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Epigenetics NGS Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Epigenetics NGS Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Epigenetics NGS Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Epigenetics NGS Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. DNA Methylation Sequencing Major Player Table 3. Histone Modification Sequencing Major Player Table 4. 3D Genome Sequencing Major Player Table 5. Others Major Player Table 6. Global Epigenetics NGS Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Clinical Diagnostics Major Player Table 8. Basic Research Major Player Table 9. Drug Development Major Player Table 10. Agricultural Breeding Major Player Table 11. Others Major Player Table 12. Epigenetics NGS Service Industry Trends Table 13. Epigenetics NGS Service Industry Drivers Table 14. Epigenetics NGS Service Industry Opportunities and Challenges Table 15. Epigenetics NGS Service Industry Restraints Table 16. Global Epigenetics NGS Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Epigenetics NGS Service Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Epigenetics NGS Service Market Share by Region (2021-2026) Table 19. Global Epigenetics NGS Service Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Epigenetics NGS Service Market Share by Region (2027-2032) Table 21. Global Epigenetics NGS Service Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Epigenetics NGS Service Revenue Market Share by Players (2021-2026) Table 23. Global Epigenetics NGS Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Epigenetics NGS Service Key Players Headquarters & Area Served Table 25. Global Epigenetics NGS Service Players, Product Type & Application Table 26. Global Epigenetics NGS Service Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Epigenetics NGS Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Epigenetics NGS Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Epigenetics NGS Service Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Epigenetics NGS Service Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Epigenetics NGS Service Revenue Market Share by Type (2021-2026) Table 33. Global Epigenetics NGS Service Revenue Market Share by Type (2027-2032) Table 34. Global Epigenetics NGS Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Epigenetics NGS Service Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Epigenetics NGS Service Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Epigenetics NGS Service Revenue Market Share by Application (2021-2026) Table 38. Global Epigenetics NGS Service Revenue Market Share by Application (2027-2032) Table 39. Active Motif Company Information Table 40. Active Motif Business Overview Table 41. Active Motif Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Active Motif Epigenetics NGS Service Product Portfolio Table 43. Active Motif Recent Development Table 44. Agilent Company Information Table 45. Agilent Business Overview Table 46. Agilent Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Agilent Epigenetics NGS Service Product Portfolio Table 48. Agilent Recent Development Table 49. Zymo Research Company Information Table 50. Zymo Research Business Overview Table 51. Zymo Research Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Zymo Research Epigenetics NGS Service Product Portfolio Table 53. Zymo Research Recent Development Table 54. Celemics Company Information Table 55. Celemics Business Overview Table 56. Celemics Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Celemics Epigenetics NGS Service Product Portfolio Table 58. Celemics Recent Development Table 59. EpiGentek Company Information Table 60. EpiGentek Business Overview Table 61. EpiGentek Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. EpiGentek Epigenetics NGS Service Product Portfolio Table 63. EpiGentek Recent Development Table 64. GENEWIZ from Azenta Company Information Table 65. GENEWIZ from Azenta Business Overview Table 66. GENEWIZ from Azenta Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. GENEWIZ from Azenta Epigenetics NGS Service Product Portfolio Table 68. GENEWIZ from Azenta Recent Development Table 69. Thermo Fisher Scientific Company Information Table 70. Thermo Fisher Scientific Business Overview Table 71. Thermo Fisher Scientific Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Thermo Fisher Scientific Epigenetics NGS Service Product Portfolio Table 73. Thermo Fisher Scientific Recent Development Table 74. GenomeScan Company Information Table 75. GenomeScan Business Overview Table 76. GenomeScan Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. GenomeScan Epigenetics NGS Service Product Portfolio Table 78. GenomeScan Recent Development Table 79. Hologic Diagenode Company Information Table 80. Hologic Diagenode Business Overview Table 81. Hologic Diagenode Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Hologic Diagenode Epigenetics NGS Service Product Portfolio Table 83. Hologic Diagenode Recent Development Table 84. Illumina Company Information Table 85. Illumina Business Overview Table 86. Illumina Epigenetics NGS Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Illumina Epigenetics NGS Service Product Portfolio Table 88. Illumina Recent Development Table 89. Macrogen Company Information Table 90. Macrogen Business Overview Table 91. Macrogen Epigenetics NGS Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Macrogen Epigenetics NGS Service Product Portfolio Table 93. Macrogen Recent Development Table 94. Novogene Company Information Table 95. Novogene Business Overview Table 96. Novogene Epigenetics NGS Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Novogene Epigenetics NGS Service Product Portfolio Table 98. Novogene Recent Development Table 99. Roche Sequencing Solutions Company Information Table 100. Roche Sequencing Solutions Business Overview Table 101. Roche Sequencing Solutions Epigenetics NGS Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Roche Sequencing Solutions Epigenetics NGS Service Product Portfolio Table 103. Roche Sequencing Solutions Recent Development Table 104. SeqMatic Company Information Table 105. SeqMatic Business Overview Table 106. SeqMatic Epigenetics NGS Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. SeqMatic Epigenetics NGS Service Product Portfolio Table 108. SeqMatic Recent Development Table 109. North America Epigenetics NGS Service Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Epigenetics NGS Service Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Epigenetics NGS Service Revenue by Application (2021-2026) & (US$ Million) Table 112. North America Epigenetics NGS Service Revenue by Application (2027-2032) & (US$ Million) Table 113. North America Epigenetics NGS Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Epigenetics NGS Service Revenue by Country (2021-2026) & (US$ Million) Table 115. North America Epigenetics NGS Service Revenue by Country (US$ Million) & (2027-2032) Table 116. Europe Epigenetics NGS Service Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Epigenetics NGS Service Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Epigenetics NGS Service Revenue by Application (2021-2026) & (US$ Million) Table 119. Europe Epigenetics NGS Service Revenue by Application (2027-2032) & (US$ Million) Table 120. Europe Epigenetics NGS Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe Epigenetics NGS Service Revenue by Country (2021-2026) & (US$ Million) Table 122. Europe Epigenetics NGS Service Revenue by Country (US$ Million) & (2027-2032) Table 123. China Epigenetics NGS Service Revenue by Type (2021-2026) & (US$ Million) Table 124. China Epigenetics NGS Service Revenue by Type (2027-2032) & (US$ Million) Table 125. China Epigenetics NGS Service Revenue by Application (2021-2026) & (US$ Million) Table 126. China Epigenetics NGS Service Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Epigenetics NGS Service Revenue by Type (2021-2026) & (US$ Million) Table 128. Asia Epigenetics NGS Service Revenue by Type (2027-2032) & (US$ Million) Table 129. Asia Epigenetics NGS Service Revenue by Application (2021-2026) & (US$ Million) Table 130. Asia Epigenetics NGS Service Revenue by Application (2027-2032) & (US$ Million) Table 131. Asia Epigenetics NGS Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Asia Epigenetics NGS Service Revenue by Region (US$ Million) & (2021-2026) Table 133. Asia Epigenetics NGS Service Revenue by Region (US$ Million) & (2027-2032) Table 134. SAMEA Epigenetics NGS Service Revenue by Type (2021-2026) & (US$ Million) Table 135. SAMEA Epigenetics NGS Service Revenue by Type (2027-2032) & (US$ Million) Table 136. SAMEA Epigenetics NGS Service Revenue by Application (2021-2026) & (US$ Million) Table 137. SAMEA Epigenetics NGS Service Revenue by Application (2027-2032) & (US$ Million) Table 138. SAMEA Epigenetics NGS Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. SAMEA Epigenetics NGS Service Revenue by Country (2021-2026) & (US$ Million) Table 140. SAMEA Epigenetics NGS Service Revenue by Country (US$ Million) & (2027-2032) Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Epigenetics NGS Service Image Figure 2. Global Epigenetics NGS Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Epigenetics NGS Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. DNA Methylation Sequencing Image Figure 5. Histone Modification Sequencing Image Figure 6. 3D Genome Sequencing Image Figure 7. Others Image Figure 8. Global Epigenetics NGS Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Epigenetics NGS Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Clinical Diagnostics Image Figure 11. Basic Research Image Figure 12. Drug Development Image Figure 13. Agricultural Breeding Image Figure 14. Others Image Figure 15. Global Epigenetics NGS Service Market Size (US$ Million) & (2021-2032) Figure 16. Global Epigenetics NGS Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Epigenetics NGS Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Epigenetics NGS Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Epigenetics NGS Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Epigenetics NGS Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Epigenetics NGS Service Revenue Market Share by Type (2021-2032) Figure 23. Global Epigenetics NGS Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Epigenetics NGS Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Epigenetics NGS Service Revenue Market Share by Application (2021-2032) Figure 26. North America Epigenetics NGS Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Epigenetics NGS Service Revenue Share by Type (2021-2032) Figure 28. North America Epigenetics NGS Service Revenue Share by Application (2021-2032) Figure 29. North America Epigenetics NGS Service Revenue Share by Country (2021-2032) Figure 30. United States Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Epigenetics NGS Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Epigenetics NGS Service Revenue Share by Type (2021-2032) Figure 35. Europe Epigenetics NGS Service Revenue Share by Application (2021-2032) Figure 36. Europe Epigenetics NGS Service Revenue Share by Country (2021-2032) Figure 37. Germany Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Epigenetics NGS Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Epigenetics NGS Service Revenue Share by Type (2021-2032) Figure 47. China Epigenetics NGS Service Revenue Share by Application (2021-2032) Figure 48. Asia Epigenetics NGS Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Epigenetics NGS Service Revenue Share by Type (2021-2032) Figure 50. Asia Epigenetics NGS Service Revenue Share by Application (2021-2032) Figure 51. Asia Epigenetics NGS Service Revenue Share by Region (2021-2032) Figure 52. Japan Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Epigenetics NGS Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Epigenetics NGS Service Revenue Share by Type (2021-2032) Figure 60. SAMEA Epigenetics NGS Service Revenue Share by Application (2021-2032) Figure 61. SAMEA Epigenetics NGS Service Revenue Share by Country (2021-2032) Figure 62. Brazil Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Epigenetics NGS Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Methylation Sequencing
  • Histone Modification Sequencing
  • 3D Genome Sequencing
  • Others
Applications
  • Clinical Diagnostics
  • Basic Research
  • Drug Development
  • Agricultural Breeding
  • Others
Companies covered
  • Active Motif
  • Agilent
  • Zymo Research
  • Celemics
  • EpiGentek
  • GENEWIZ from Azenta
  • Thermo Fisher Scientific
  • GenomeScan
  • Hologic Diagenode
  • Illumina
  • Macrogen
  • Novogene
  • Roche Sequencing Solutions
  • SeqMatic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Epigenetics NGS Service Market by Type
  3. 1.2.1 Global Epigenetics NGS Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 DNA Methylation Sequencing
  5. 1.2.3 Histone Modification Sequencing
  6. 1.2.4 3D Genome Sequencing
  7. 1.2.5 Others
  8. 1.3 Epigenetics NGS Service Market by Application
  9. 1.3.1 Global Epigenetics NGS Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Clinical Diagnostics
  11. 1.3.3 Basic Research
  12. 1.3.4 Drug Development
  13. 1.3.5 Agricultural Breeding
  14. 1.3.6 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Epigenetics NGS Service Market Dynamics
  1. 2.1 Epigenetics NGS Service Industry Trends
  2. 2.2 Epigenetics NGS Service Industry Drivers
  3. 2.3 Epigenetics NGS Service Industry Opportunities and Challenges
  4. 2.4 Epigenetics NGS Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Epigenetics NGS Service Market Perspective (2021-2032)
  2. 3.2 Global Epigenetics NGS Service Growth Trends by Region
  3. 3.2.1 Global Epigenetics NGS Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Epigenetics NGS Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Epigenetics NGS Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Epigenetics NGS Service Revenue by Players
  2. 4.1.1 Global Epigenetics NGS Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Epigenetics NGS Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Epigenetics NGS Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Epigenetics NGS Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Epigenetics NGS Service Key Players Headquarters & Area Served
  7. 4.4 Global Epigenetics NGS Service Players, Product Type & Application
  8. 4.5 Global Epigenetics NGS Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Epigenetics NGS Service Market CR5 and HHI
  11. 4.6.3 2025 Epigenetics NGS Service Tier 1, Tier 2, and Tier 3
5 Epigenetics NGS Service Market Size by Type
  1. 5.1 Global Epigenetics NGS Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Epigenetics NGS Service Revenue by Type (2021-2032)
  3. 5.3 Global Epigenetics NGS Service Revenue Market Share by Type (2021-2032)
6 Epigenetics NGS Service Market Size by Application
  1. 6.1 Global Epigenetics NGS Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Epigenetics NGS Service Revenue by Application (2021-2032)
  3. 6.3 Global Epigenetics NGS Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Active Motif
  2. 7.1.1 Active Motif Company Information
  3. 7.1.2 Active Motif Business Overview
  4. 7.1.3 Active Motif Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Active Motif Epigenetics NGS Service Product Portfolio
  6. 7.1.5 Active Motif Recent Developments
  7. 7.2 Agilent
  8. 7.2.1 Agilent Company Information
  9. 7.2.2 Agilent Business Overview
  10. 7.2.3 Agilent Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Agilent Epigenetics NGS Service Product Portfolio
  12. 7.2.5 Agilent Recent Developments
  13. 7.3 Zymo Research
  14. 7.3.1 Zymo Research Company Information
  15. 7.3.2 Zymo Research Business Overview
  16. 7.3.3 Zymo Research Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Zymo Research Epigenetics NGS Service Product Portfolio
  18. 7.3.5 Zymo Research Recent Developments
  19. 7.4 Celemics
  20. 7.4.1 Celemics Company Information
  21. 7.4.2 Celemics Business Overview
  22. 7.4.3 Celemics Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Celemics Epigenetics NGS Service Product Portfolio
  24. 7.4.5 Celemics Recent Developments
  25. 7.5 EpiGentek
  26. 7.5.1 EpiGentek Company Information
  27. 7.5.2 EpiGentek Business Overview
  28. 7.5.3 EpiGentek Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 EpiGentek Epigenetics NGS Service Product Portfolio
  30. 7.5.5 EpiGentek Recent Developments
  31. 7.6 GENEWIZ from Azenta
  32. 7.6.1 GENEWIZ from Azenta Company Information
  33. 7.6.2 GENEWIZ from Azenta Business Overview
  34. 7.6.3 GENEWIZ from Azenta Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GENEWIZ from Azenta Epigenetics NGS Service Product Portfolio
  36. 7.6.5 GENEWIZ from Azenta Recent Developments
  37. 7.7 Thermo Fisher Scientific
  38. 7.7.1 Thermo Fisher Scientific Company Information
  39. 7.7.2 Thermo Fisher Scientific Business Overview
  40. 7.7.3 Thermo Fisher Scientific Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Thermo Fisher Scientific Epigenetics NGS Service Product Portfolio
  42. 7.7.5 Thermo Fisher Scientific Recent Developments
  43. 7.8 GenomeScan
  44. 7.8.1 GenomeScan Company Information
  45. 7.8.2 GenomeScan Business Overview
  46. 7.8.3 GenomeScan Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 GenomeScan Epigenetics NGS Service Product Portfolio
  48. 7.8.5 GenomeScan Recent Developments
  49. 7.9 Hologic Diagenode
  50. 7.9.1 Hologic Diagenode Company Information
  51. 7.9.2 Hologic Diagenode Business Overview
  52. 7.9.3 Hologic Diagenode Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Hologic Diagenode Epigenetics NGS Service Product Portfolio
  54. 7.9.5 Hologic Diagenode Recent Developments
  55. 7.10 Illumina
  56. 7.10.1 Illumina Company Information
  57. 7.10.2 Illumina Business Overview
  58. 7.10.3 Illumina Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Illumina Epigenetics NGS Service Product Portfolio
  60. 7.10.5 Illumina Recent Developments
  61. 7.11 Macrogen
  62. 7.11.1 Macrogen Company Information
  63. 7.11.2 Macrogen Business Overview
  64. 7.11.3 Macrogen Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Macrogen Epigenetics NGS Service Product Portfolio
  66. 7.11.5 Macrogen Recent Developments
  67. 7.12 Novogene
  68. 7.12.1 Novogene Company Information
  69. 7.12.2 Novogene Business Overview
  70. 7.12.3 Novogene Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Novogene Epigenetics NGS Service Product Portfolio
  72. 7.12.5 Novogene Recent Developments
  73. 7.13 Roche Sequencing Solutions
  74. 7.13.1 Roche Sequencing Solutions Company Information
  75. 7.13.2 Roche Sequencing Solutions Business Overview
  76. 7.13.3 Roche Sequencing Solutions Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Roche Sequencing Solutions Epigenetics NGS Service Product Portfolio
  78. 7.13.5 Roche Sequencing Solutions Recent Developments
  79. 7.14 SeqMatic
  80. 7.14.1 SeqMatic Company Information
  81. 7.14.2 SeqMatic Business Overview
  82. 7.14.3 SeqMatic Epigenetics NGS Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 SeqMatic Epigenetics NGS Service Product Portfolio
  84. 7.14.5 SeqMatic Recent Developments
8 North America
  1. 8.1 North America Epigenetics NGS Service Revenue (2021-2032)
  2. 8.2 North America Epigenetics NGS Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Epigenetics NGS Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Epigenetics NGS Service Revenue by Type (2027-2032)
  5. 8.3 North America Epigenetics NGS Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Epigenetics NGS Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Epigenetics NGS Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Epigenetics NGS Service Revenue by Application (2027-2032)
  9. 8.5 North America Epigenetics NGS Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Epigenetics NGS Service Revenue by Country
  11. 8.6.1 North America Epigenetics NGS Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Epigenetics NGS Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Epigenetics NGS Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Epigenetics NGS Service Revenue (2021-2032)
  2. 9.2 Europe Epigenetics NGS Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Epigenetics NGS Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Epigenetics NGS Service Revenue by Type (2027-2032)
  5. 9.3 Europe Epigenetics NGS Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Epigenetics NGS Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Epigenetics NGS Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Epigenetics NGS Service Revenue by Application (2027-2032)
  9. 9.5 Europe Epigenetics NGS Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Epigenetics NGS Service Revenue by Country
  11. 9.6.1 Europe Epigenetics NGS Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Epigenetics NGS Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Epigenetics NGS Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Epigenetics NGS Service Revenue (2021-2032)
  2. 10.2 China Epigenetics NGS Service Revenue by Type (2021-2032)
  3. 10.2.1 China Epigenetics NGS Service Revenue by Type (2021-2026)
  4. 10.2.2 China Epigenetics NGS Service Revenue by Type (2027-2032)
  5. 10.3 China Epigenetics NGS Service Revenue Share by Type (2021-2032)
  6. 10.4 China Epigenetics NGS Service Revenue by Application (2021-2032)
  7. 10.4.1 China Epigenetics NGS Service Revenue by Application (2021-2026)
  8. 10.4.2 China Epigenetics NGS Service Revenue by Application (2027-2032)
  9. 10.5 China Epigenetics NGS Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Epigenetics NGS Service Revenue (2021-2032)
  2. 11.2 Asia Epigenetics NGS Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Epigenetics NGS Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Epigenetics NGS Service Revenue by Type (2027-2032)
  5. 11.3 Asia Epigenetics NGS Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Epigenetics NGS Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Epigenetics NGS Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Epigenetics NGS Service Revenue by Application (2027-2032)
  9. 11.5 Asia Epigenetics NGS Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Epigenetics NGS Service Revenue by Country
  11. 11.6.1 Asia Epigenetics NGS Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Epigenetics NGS Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Epigenetics NGS Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Epigenetics NGS Service Revenue (2021-2032)
  2. 12.2 SAMEA Epigenetics NGS Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Epigenetics NGS Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Epigenetics NGS Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Epigenetics NGS Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Epigenetics NGS Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Epigenetics NGS Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Epigenetics NGS Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Epigenetics NGS Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Epigenetics NGS Service Revenue by Country
  11. 12.6.1 SAMEA Epigenetics NGS Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Epigenetics NGS Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Epigenetics NGS Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst